You have a project and would like to have access to our equipments and unique expertise?
Infrastructure de Recherche RMN (FR3050)
Since 2008 France has established a national network of flagship NMR facilities providing High-Resolution and High-Field capabilities, making available the latest cutting edge developments to a broad community of national and international users.
This multi-sited structure features research teams of international visibility providing a unique combinations of high-cost and high-performance instruments and associated skills in development of methods and application to biology, chemistry, physics, geology, or materials sciences.
The Lyon site is committed to provide one third of its experimental time on the three highest end magnets (1000, 800 WB and 800 NB) and associated expertise [300 days per year] to the community, through a constantly open call for proposals.
Infrastructure for NMR, EM and X-rays for Translational Research
The iNEXT-Discovery consortium aims to facilitate the generation of knowledge for the development of new drugs, advanced vaccines, novel biomaterials, engineered enzymes for food production, efficient biofuels, and other benefits. iNEXT-Discovery will do that by enabling leading European facilities to offer advanced technological instrumentation and expertise to all European scientists, allowing them to perform high-end structural biology research with state-of-the-art equipment that is often unavailable in their home countries.
Une plateforme RMN d’excellence centrée entreprise au service de l’innovation en chimie et santé
As part of the IRICE program (Installations de Recherche et d’Innovation Centrées Entreprises) of the Auvergne-Rhône-Alpes Region, the CRMN has been funded a 3.2 M€ project ("An NMR platform centered on excellence in the service of the innovation in chemistry and health "), to undertake a major upgrade of the NMR platform (consoles and last generation probes). Supported by competitiveness clusters, notably Axelera and Lyonbiopôle, by research institutes such as Bioaster and Canceropôle Clara, and a first circle of companies in the Region, the project aims to provide regional companies with integrated access to our NMR platform to meet their growing needs in terms of analytical characterization in the fields of chemistry and health, and more generally will help to increase the NMR's visibility to regional socio-economic actors, its integration into the innovation ecosystem, and the transfer of technology.